139 related articles for article (PubMed ID: 36987394)
1. The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer.
Ozveren A; Ridvanogullari Donger M; Motor S; Bulut G
Integr Cancer Ther; 2023; 22():15347354231165938. PubMed ID: 36987394
[TBL] [Abstract][Full Text] [Related]
2. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
[TBL] [Abstract][Full Text] [Related]
3. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
4. Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay.
Muniz J; Kidwell KM; Henry NL
Breast Cancer Res Treat; 2016 Jun; 157(3):597-603. PubMed ID: 27271766
[TBL] [Abstract][Full Text] [Related]
5. A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor.
Colonna SV; Douglas Case L; Lawrence JA
Breast Cancer Res Treat; 2012 Jan; 131(1):325-31. PubMed ID: 21964613
[TBL] [Abstract][Full Text] [Related]
6. The Association between Abdominal Obesity, Metabolic Syndrome and Survival Outcomes in Patients with Breast Cancer.
Taroeno-Hariadi KW; Putra YR; Ariesta NF; Sinorita H; Hardianti MS; Widodo I; Aryandono T
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3157-3165. PubMed ID: 36172679
[TBL] [Abstract][Full Text] [Related]
7. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.
Capasso I; Esposito E; Pentimalli F; Montella M; Crispo A; Maurea N; D'Aiuto M; Fucito A; Grimaldi M; Cavalcanti E; Esposito G; Brillante G; Lodato S; Pedicini T; D'Aiuto G; Ciliberto G; Giordano A
J Exp Clin Cancer Res; 2013 Mar; 32(1):14. PubMed ID: 23497533
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.
Capasso I; Esposito E; Pentimalli F; Crispo A; Montella M; Grimaldi M; De Marco M; Cavalcanti E; D'Aiuto M; Fucito A; Frasci G; Maurea N; Esposito G; Pedicini T; Vecchione A; D'Aiuto G; Giordano A
Cancer Biol Ther; 2010 Dec; 10(12):1240-3. PubMed ID: 20935521
[TBL] [Abstract][Full Text] [Related]
9. High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
Criscitiello C; Disalvatore D; De Laurentiis M; Gelao L; Fumagalli L; Locatelli M; Bagnardi V; Rotmensz N; Esposito A; Minchella I; De Placido S; Santangelo M; Viale G; Goldhirsch A; Curigliano G
Breast; 2014 Feb; 23(1):69-75. PubMed ID: 24314620
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic obesity in early breast cancer patients with metabolic syndrome: a cross-sectional study.
Bulut G; Atci N
Future Oncol; 2022 Jun; 18(20):2489-2498. PubMed ID: 35543029
[No Abstract] [Full Text] [Related]
11. Relationship Between Metabolic Syndrome and Postmenopausal Breast Cancer.
Ekinci O; Eren T; Kurtoglu Yakici M; Gapbarov A; Aydemir MA; Saglam ZA; Alimoglu O
Cir Esp (Engl Ed); 2020 Nov; 98(9):540-546. PubMed ID: 32197778
[TBL] [Abstract][Full Text] [Related]
12. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
13. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and its related biochemical derangements in breast cancer patients who received neoadjuvant chemotherapy: A study from a tertiary care oncology centre from Puducherry, South India.
Gomes SL; Bobby Z; Ganesan P; Saroja K; Parameswari G R
Diabetes Metab Syndr; 2021; 15(3):975-980. PubMed ID: 33962149
[TBL] [Abstract][Full Text] [Related]
15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
16. Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study.
Fredslund SO; Gravholt CH; Laursen BE; Jensen AB
J Transl Med; 2019 Apr; 17(1):105. PubMed ID: 30935397
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.
Thomson CA; Thompson PA; Wright-Bea J; Nardi E; Frey GR; Stopeck A
J Womens Health (Larchmt); 2009 Dec; 18(12):2041-7. PubMed ID: 20044868
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.
Arpino G; De Angelis C; Buono G; Colao A; Giuliano M; Malgieri S; Cicala S; De Laurentiis M; Accurso A; Crispo A; Limite G; Lauria R; Veneziani BM; Forestieri V; Bruzzese D; De Placido S
Breast Cancer Res Treat; 2015 Nov; 154(1):127-32. PubMed ID: 26424165
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of body mass index in breast cancer patients with hormone receptor-positive tumours after curative surgery.
Xing P; Li JG; Jin F; Zhao TT; Liu Q; Dong HT; Wei XL
Clin Invest Med; 2013 Dec; 36(6):E297-305. PubMed ID: 24309226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
